Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,767 | 76 | 64.5% |
| Travel and Lodging | $971.94 | 1 | 35.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PROCEPT BioRobotics Corporation | $1,008 | 2 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $195.84 | 8 | $0 (2024) |
| Teleflex LLC | $192.26 | 5 | $0 (2024) |
| Boston Scientific Corporation | $184.44 | 8 | $0 (2024) |
| Astellas Pharma US Inc | $146.12 | 8 | $0 (2023) |
| Sumitomo Pharma America, Inc. | $106.12 | 7 | $0 (2024) |
| Tolmar, Inc. | $100.53 | 2 | $0 (2023) |
| Janssen Scientific Affairs, LLC | $98.96 | 1 | $0 (2018) |
| C. R. Bard, Inc. & Subsidiaries | $95.81 | 1 | $0 (2018) |
| Janssen Biotech, Inc. | $82.25 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,347 | 17 | PROCEPT BioRobotics Corporation ($1,008) |
| 2023 | $332.61 | 16 | Tolmar, Inc. ($100.53) |
| 2022 | $231.67 | 7 | Teleflex LLC ($125.00) |
| 2021 | $76.11 | 4 | Laborie Medical Technologies Corp. ($31.35) |
| 2020 | $41.62 | 3 | Astellas Pharma US Inc ($17.90) |
| 2019 | $145.43 | 7 | Dendreon Pharmaceuticals LLC ($88.25) |
| 2018 | $384.15 | 12 | Janssen Scientific Affairs, LLC ($98.96) |
| 2017 | $180.78 | 11 | Astellas Pharma US Inc ($43.65) |
All Payment Transactions
77 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | COLOPLAST CORP | Altis (Device) | Food and Beverage | In-kind items and services | $26.91 | General |
| Category: Women's Health | ||||||
| 10/30/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: UROTHELIAL CANCER | ||||||
| 10/15/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 09/24/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Oncology | ||||||
| 09/18/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Travel and Lodging | Cash or cash equivalent | $971.94 | General |
| Category: UROLOGY | ||||||
| 09/18/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: UROLOGY | ||||||
| 08/07/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: ONCOLOGY | ||||||
| 07/10/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: UROLOGY | ||||||
| 05/31/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $28.97 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/22/2024 | Laborie Medical Technologies Corp. | Optilume BPH Drug Coated Balloon Catheter (Device) | Food and Beverage | Cash or cash equivalent | $27.51 | General |
| Category: Urology | ||||||
| 04/25/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $36.21 | General |
| Category: UROLOGY | ||||||
| 04/18/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $44.33 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 04/02/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 03/28/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: UROLOGY | ||||||
| 02/21/2024 | Boston Scientific Corporation | Tria Firm (Device) | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: Tria_URO | ||||||
| 01/31/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: ONCOLOGY | ||||||
| 01/10/2024 | COLOPLAST CORP | Altis (Device) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: Women's Health | ||||||
| 11/15/2023 | UroGen Pharma, Inc. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: UROTHELIAL CANCER | ||||||
| 10/11/2023 | Photocure Inc | CYSVIEW (Drug) | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: ONCOLOGY | ||||||
| 09/29/2023 | Tolmar, Inc. | ELIGARD (Drug) | Food and Beverage | In-kind items and services | $86.98 | General |
| Category: Prostate Cancer | ||||||
| 09/27/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Urology | ||||||
| 09/21/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: Urology | ||||||
| 09/20/2023 | Tolmar, Inc. | ELIGARD (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: Prostate Cancer | ||||||
| 09/15/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: General - Kidney Stone Disease_URO | ||||||
| 08/23/2023 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: HORMONE THERAPY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 2,087 | 5,284 | $507,257 | $185,528 |
| 2022 | 25 | 2,222 | 5,224 | $442,860 | $160,138 |
| 2021 | 23 | 2,239 | 5,096 | $436,075 | $162,166 |
| 2020 | 19 | 1,730 | 2,368 | $282,387 | $117,937 |
All Medicare Procedures & Services
91 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 13 | 2,460 | $79,237 | $45,206 | 57.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 387 | 521 | $126,635 | $42,960 | 33.9% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 24 | 168 | $116,088 | $22,453 | 19.3% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 73 | 87 | $22,431 | $14,724 | 65.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 136 | 136 | $43,459 | $14,328 | 33.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 138 | 157 | $26,237 | $9,006 | 34.3% |
| 52601 | Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | Facility | 2023 | 12 | 12 | $12,224 | $6,017 | 49.2% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 48 | 51 | $6,943 | $5,105 | 73.5% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 42 | 79 | $5,925 | $3,724 | 62.9% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 19 | 19 | $4,465 | $3,409 | 76.3% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 406 | 494 | $12,455 | $3,233 | 26.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 16 | 16 | $5,600 | $2,161 | 38.6% |
| 99426 | Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 25 | 43 | $3,225 | $1,981 | 61.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 18 | 18 | $4,621 | $1,779 | 38.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 22 | 22 | $5,410 | $1,513 | 28.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 335 | 427 | $6,405 | $1,450 | 22.6% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 245 | 347 | $5,377 | $1,353 | 25.2% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 13 | 24 | $3,246 | $1,165 | 35.9% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 12 | 14 | $7,900 | $1,071 | 13.6% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 22 | 28 | $1,680 | $997.92 | 59.4% |
| 52005 | Insertion of tube into ureter using an endoscope through bladder area | Facility | 2023 | 11 | 12 | $3,564 | $861.80 | 24.2% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 24 | 28 | $1,988 | $548.27 | 27.6% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 24 | 29 | $1,223 | $446.94 | 36.5% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 22 | 92 | $920.00 | $36.10 | 3.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 378 | 503 | $67,552 | $41,802 | 61.9% |
About Dr. Christopher Thacker, M.D
Dr. Christopher Thacker, M.D is a Urology healthcare provider based in Cleveland, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1881658664.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Thacker, M.D has received a total of $2,739 in payments from pharmaceutical and medical device companies, with $1,347 received in 2024. These payments were reported across 77 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($1,767).
As a Medicare-enrolled provider, Thacker has provided services to 8,278 Medicare beneficiaries, totaling 17,972 services with total Medicare billing of $625,769. Data is available for 4 years (2020–2023), covering 91 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Cleveland, TN
- Active Since 04/17/2006
- Last Updated 10/23/2007
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1881658664
Products in Payments
- AQUABEAM SYSTEM (Device) $1,008
- PROVENGE (Drug) $195.84
- UroLift System (Device) $141.76
- Erleada (Drug) $111.39
- ELIGARD (Drug) $100.53
- INLAY OPTIMA (Device) $95.81
- GEMTESA (Drug) $93.32
- Myrbetriq (Drug) $90.67
- ERLEADA (Drug) $69.82
- GENERAL ERECTILE DYSFUNCTION (Device) $53.84
- UROLIFT (Device) $50.50
- General - Kidney Stone Disease (Device) $50.13
- Lupron (Drug) $48.17
- Altis (Device) $47.65
- XTANDI (Drug) $44.00
- JELMYTO (Drug) $41.21
- MYRBETRIQ (Drug) $34.46
- Rezum (Device) $33.89
- Prolia (Biological) $33.41
- Noctiva (Drug) $29.45
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Cleveland
Howard Goldman, Md, MD
Urology — Payments: $688,743
Jihad Kaouk, Md, MD
Urology — Payments: $258,551
Sandip Vasavada, Md, MD
Urology — Payments: $247,878
Petar Bajic, M.d, M.D
Urology — Payments: $238,227
Dr. Sriharan Sivalingam, Md, MD
Urology — Payments: $210,140
Ruben Olivares, Md, MD
Urology — Payments: $174,034